Liuichi HARA, MS 2013 - MBA 2012, Global Project Director, Commercial Excellence at Novo Nordisk

Novo Nordisk, a global leader in healthcare, has recently announced the appointment of Liuichi Hara, a graduate of Grenoble École de Management (MS Bio Tech 2013 - MBA 2012), as Global Director, Commercial Excellence.

Based in Denmark and with an international career and diverse experience, Liuichi has held several key roles within the company, including Global Project Director for the Cell Therapy Commercial Unit and Head of PMO for Global Contract Manufacturing.

As a GEM MBA graduate, Liuichi has also shared his expertise and supported the next generation of leaders in their professional development as a mentor for the MBA program at GEM.

About Novo Nordisk

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Novo Nordisk's treatments are benefiting millions of people living with diabetes, obesity, and rare blood and endocrine diseases.  Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries.